Takeshi Ushigusa
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 13, 2025
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol.Takeshi Ushigusa, Nami Hirakawa, Naoki Kanomata
|Apr 13, 2025
Reply to the letter to the editor "Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients".Takeshi Ushigusa, Atsushi Yoshida, Naoki Kanomata
|Mar 17, 2025
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study.Takeshi Ushigusa, Nami Hirakawa, Yuka Kajiura
|Dec 27, 2024
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study.Takeshi Ushigusa, Nami Hirakawa, Yuka Kajiura
Pageof 1